Levetiracetam clinical pharmacokinetics in elderly and very elderly patients with epilepsy

M. Contin; S. Mohamed; F. Albani; R. Riva; A. Baruzzi

doi:10.1016/j.eplepsyres.2011.08.020

Levetiracetam clinical pharmacokinetics in elderly and very elderly patients with epilepsy

M. Contin, S. Mohamed, F. Albani, R. Riva, A. Baruzzi

Istituto Scienze Neurologiche

Research output: Contribution to journal › Article

Abstract

We aimed to compare apparent steady-state oral clearance (CL/F) of the antiepileptic drug levetiracetam (LEV) in elderly (66-80 years, n=105) and very elderly (81-96 years, n=70) vs nonelderly (30-65 years, n=97) patients with epilepsy. Median weight-normalized CL/F (mLmin ^-1kg ^-1) decreased from 1.23 (nonelderly) to 0.83 (elderly) and 0.59 (very elderly) (p

Original language	English
Pages (from-to)	130-134
Number of pages	5
Journal	Epilepsy Research
Volume	98
Issue number	2-3
DOIs	https://doi.org/10.1016/j.eplepsyres.2011.08.020
Publication status	Published - Feb 2012

Fingerprint

Keywords

Elderly and very elderly patients
Levetiracetam
Oral clearance
Pharmacokinetics
Therapeutic drug monitoring

ASJC Scopus subject areas

Clinical Neurology
Neurology

Cite this

Contin, M., Mohamed, S., Albani, F., Riva, R., & Baruzzi, A. (2012). Levetiracetam clinical pharmacokinetics in elderly and very elderly patients with epilepsy. Epilepsy Research, 98(2-3), 130-134. https://doi.org/10.1016/j.eplepsyres.2011.08.020

@article{23c34c24c1bf415cbb35fbbf828f1d6e,

title = "Levetiracetam clinical pharmacokinetics in elderly and very elderly patients with epilepsy",

abstract = "We aimed to compare apparent steady-state oral clearance (CL/F) of the antiepileptic drug levetiracetam (LEV) in elderly (66-80 years, n=105) and very elderly (81-96 years, n=70) vs nonelderly (30-65 years, n=97) patients with epilepsy. Median weight-normalized CL/F (mLmin -1kg -1) decreased from 1.23 (nonelderly) to 0.83 (elderly) and 0.59 (very elderly) (p",

keywords = "Elderly and very elderly patients, Levetiracetam, Oral clearance, Pharmacokinetics, Therapeutic drug monitoring",

author = "M. Contin and S. Mohamed and F. Albani and R. Riva and A. Baruzzi",

year = "2012",

month = feb

doi = "10.1016/j.eplepsyres.2011.08.020",

language = "English",

volume = "98",

pages = "130--134",

journal = "Epilepsy Research",

issn = "0920-1211",

publisher = "Elsevier",

number = "2-3",

}

TY - JOUR

T1 - Levetiracetam clinical pharmacokinetics in elderly and very elderly patients with epilepsy

AU - Contin, M.

AU - Mohamed, S.

AU - Albani, F.

AU - Riva, R.

AU - Baruzzi, A.

PY - 2012/2

Y1 - 2012/2

N2 - We aimed to compare apparent steady-state oral clearance (CL/F) of the antiepileptic drug levetiracetam (LEV) in elderly (66-80 years, n=105) and very elderly (81-96 years, n=70) vs nonelderly (30-65 years, n=97) patients with epilepsy. Median weight-normalized CL/F (mLmin -1kg -1) decreased from 1.23 (nonelderly) to 0.83 (elderly) and 0.59 (very elderly) (p

AB - We aimed to compare apparent steady-state oral clearance (CL/F) of the antiepileptic drug levetiracetam (LEV) in elderly (66-80 years, n=105) and very elderly (81-96 years, n=70) vs nonelderly (30-65 years, n=97) patients with epilepsy. Median weight-normalized CL/F (mLmin -1kg -1) decreased from 1.23 (nonelderly) to 0.83 (elderly) and 0.59 (very elderly) (p

KW - Elderly and very elderly patients

KW - Levetiracetam

KW - Oral clearance

KW - Pharmacokinetics

KW - Therapeutic drug monitoring

UR - http://www.scopus.com/inward/record.url?scp=84856427715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856427715&partnerID=8YFLogxK

U2 - 10.1016/j.eplepsyres.2011.08.020

DO - 10.1016/j.eplepsyres.2011.08.020

M3 - Article

C2 - 21944894

AN - SCOPUS:84856427715

VL - 98

SP - 130

EP - 134

JO - Epilepsy Research

JF - Epilepsy Research

SN - 0920-1211

IS - 2-3

ER -

Access to Document

10.1016/j.eplepsyres.2011.08.020